New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 29, 2014
07:16 EDTCAVMCavium should be bought on any weakness after results, says Oppenheimer
Oppenheimer expects Cavium to report stronger than expected Q1 results, but notes that the stock has dropped following modest beat and raise results in the past. The firm recommends buying the stock on any weakness after the results, as it expects the company's revenue to rise significantly in 2H14. The firm reiterates a $48 price target and Outperform rating on the shares.
News For CAVM From The Last 14 Days
Check below for free stories on CAVM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 14, 2014
05:52 EDTCAVMOpco sees Cicso results as favorable for supply chain
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use